DENTSPLY SIRONA (NASDAQ:XRAY) Lowered to Hold Rating by Jefferies Financial Group

Jefferies Financial Group downgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a buy rating to a hold rating in a report published on Thursday, Marketbeat reports. They currently have $20.00 price target on the medical instruments supplier’s stock, down from their previous price target of $30.00.

XRAY has been the subject of a number of other reports. Mizuho initiated coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 price objective for the company. Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Leerink Partnrs cut shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Morgan Stanley reduced their target price on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a research note on Tuesday, December 17th. Finally, Needham & Company LLC dropped their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Ten research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $26.67.

DENTSPLY SIRONA Stock Up 0.4 %

Shares of XRAY opened at $19.44 on Thursday. The company’s 50 day simple moving average is $18.98 and its 200-day simple moving average is $22.74. DENTSPLY SIRONA has a 12-month low of $17.21 and a 12-month high of $35.68. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. During the same period in the previous year, the business posted $0.49 earnings per share. DENTSPLY SIRONA’s quarterly revenue was up .4% on a year-over-year basis. Sell-side analysts expect that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Friday, December 27th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $0.64 dividend on an annualized basis and a yield of 3.29%. DENTSPLY SIRONA’s payout ratio is -30.92%.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of large investors have recently added to or reduced their stakes in the business. State of Alaska Department of Revenue lifted its holdings in shares of DENTSPLY SIRONA by 2.4% in the third quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock valued at $637,000 after purchasing an additional 560 shares in the last quarter. UMB Bank n.a. lifted its stake in DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after buying an additional 564 shares in the last quarter. MML Investors Services LLC lifted its stake in DENTSPLY SIRONA by 2.1% in the 3rd quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier’s stock valued at $803,000 after buying an additional 620 shares in the last quarter. Allworth Financial LP increased its position in DENTSPLY SIRONA by 40.2% during the third quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock worth $59,000 after buying an additional 625 shares in the last quarter. Finally, Blue Trust Inc. increased its position in DENTSPLY SIRONA by 10.9% during the fourth quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier’s stock worth $137,000 after buying an additional 707 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.